Comparison

PneumoRecs VaxAdvisor vs Circadia Talkie

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

PneumoRecs VaxAdvisor

This application offers personalized pneumococcal vaccination guidance based on patient age, vaccination history, and medical conditions. It aligns with the Advisory Committee on Immunization Practices' recommendations for U.S. immunization schedules.

Highlights
  • Patient-specific vaccination recommendations
  • Age-based guidance
  • Vaccination history tracking
  • Underlying medical condition prompts
  • U.S. immunization schedule compliance
Features
Read full description

This is the PneumoRecs VaxAdvisor App created by the Centers for Disease Control and Prevention (CDC) in collaboration with the Georgia Tech Research Institute. PneumoRecs VaxAdvisor provides patient-specific pneumococcal vaccination guidance consistent with the pneumococcal vaccination recommendations of the Advisory Committee on Immunization Practices. Vaccination providers enter a patient’s age and respond to prompts about the patient’s pneumococcal vaccination history and underlying medical conditions. The app then displays patient-specific pneumococcal vaccination recommendations consistent with the recommended U.S. immunization schedule.

About

Circadia Talkie

Features
Read full description

Circadia Talkie enables two-way communication with patients by calling the Circadia C100 device next to their bed. Use your Circadia account to log in and choose from a list of patients by their name and room number.

Screenshots

PneumoRecs VaxAdvisor2 screens
Circadia Talkie2 screens

Verdict

The call

The clearest difference is iOS requirement: Circadia Talkie at 15.0 against PneumoRecs VaxAdvisor's 18.0. On price, update cadence, ads and in-app purchases there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

PneumoRecs VaxAdvisor ships an update every 3 months, Circadia Talkie every 6 weeks. The most recent releases landed on November 3, 2026 and October 30, 2026 respectively.

Scorecard1 real difference · 9 level
PneumoRecs VaxAdvisor versus Circadia Talkie: the parameters behind the verdict, then further details
ParameterPneumoRecs VaxAdvisorCircadia Talkie
PriceFreeFree
Rating3.4 (60 ratings) — better—
Positive reviews26.9% of reviews—
Number of ratings60 — better—
Update frequencyEvery 3 monthsEvery 6 weeks — better
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS18.015.0 — better
Further details — not scored
Size6 MB34 MB
Age rating17+17+
DeveloperCenters For Disease Control and PreventionCircadia Technologies Ltd.

In-app purchases

None

PneumoRecs VaxAdvisor

No in-app purchases

None

Circadia Talkie

No in-app purchases

Questions

Is PneumoRecs VaxAdvisor free?
PneumoRecs VaxAdvisor is free to download, with no in-app purchases.
Is Circadia Talkie free?
Circadia Talkie is free to download, with no in-app purchases.
Do PneumoRecs VaxAdvisor or Circadia Talkie have ads?
Neither PneumoRecs VaxAdvisor nor Circadia Talkie shows ads.
Which is updated more often, PneumoRecs VaxAdvisor or Circadia Talkie?
PneumoRecs VaxAdvisor ships an update every 3 months, and Circadia Talkie every 6 weeks. Most recently, PneumoRecs VaxAdvisor was updated on November 3, 2026 and Circadia Talkie on October 30, 2026.

Other comparisons